ScoreWhy is Yixintang Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 5.56% and Operating profit at -13.28% over the last 5 years
2
Positive results in Mar 26
- RAW MATERIAL COST(Y) Fallen by -6.01% (YoY)
- DEBT-EQUITY RATIO (HY) Lowest at 8.19 %
- PRE-TAX PROFIT(Q) Highest at CNY 225.94 MM
3
With ROE of 3.78%, it has a fair valuation with a 0.59 Price to Book Value
- Over the past year, while the stock has generated a return of -37.29%, its profits have risen by 414.2% ; the PEG ratio of the company is 0
- At the current price, the company has a high dividend yield of 5.4
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -37.29% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Yixintang Pharmaceutical Group Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Retailing should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Yixintang Pharmaceutical Group Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Yixintang Pharmaceutical Group Co., Ltd.
-26.59%
-1.51
27.91%
China Shanghai Composite
0.9%
1.20
14.07%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.56%
EBIT Growth (5y)
-13.28%
EBIT to Interest (avg)
5.52
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
1.61
Tax Ratio
32.41%
Dividend Payout Ratio
87.51%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.07%
ROE (avg)
9.80%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
0.77
EV to EBIT
11.43
EV to EBITDA
3.44
EV to Capital Employed
0.76
EV to Sales
0.31
PEG Ratio
0.05
Dividend Yield
4.12%
ROCE (Latest)
6.61%
ROE (Latest)
3.78%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
DIVIDEND PAYOUT RATIO(Y)
Highest at 141.64%
RAW MATERIAL COST(Y)
Fallen by 0.16% (YoY
NET PROFIT(9M)
Higher at CNY 250.31 MM
DEBT-EQUITY RATIO
(HY)
Lowest at 9.57 %
-1What is not working for the Company
NET SALES(Q)
Lowest at CNY 4,033.6 MM
Here's what is working for Yixintang Pharmaceutical Group Co., Ltd.
Net Profit
At CNY 250.31 MM has Grown at 155.27%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Debt-Equity Ratio
Lowest at 9.57 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Net Profit
Higher at CNY 250.31 MM
than preceding 12 month period ended Jun 2026MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Profit (CNY MM)
Dividend Payout Ratio
Highest at 141.64%
in the last five yearsMOJO Watch
Company is distributing higher proportion of profits generated as dividend
DPR (%)
Raw Material Cost
Fallen by 0.16% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Yixintang Pharmaceutical Group Co., Ltd.
Net Sales
Lowest at CNY 4,033.6 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Footer loading
